Correction: NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL

C Prieto; B López-Millán; H Roca-Ho; R W Stam; D Romero-Moya; F J Rodríguez-Baena; A Sanjuan-Pla; V Ayllón; M Ramírez; M Bardini; P De Lorenzo; M G Valsecchi; M Stanulla; M Iglesias; P Ballerini; Á M Carcaboso; J Mora; F Locatelli; A Bertaina; L Padilla; Juan Carlos Rodríguez-Manzaneque; C Bueno; P Menéndez

doi:10.1038/s41375-018-0236-4

Correction: NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL

Leukemia. 2018 Oct;32(10):2306. doi: 10.1038/s41375-018-0236-4.

Authors

C Prieto¹, B López-Millán¹, H Roca-Ho¹, R W Stam^{2

3}, D Romero-Moya¹, F J Rodríguez-Baena⁴, A Sanjuan-Pla¹, V Ayllón⁴, M Ramírez⁵, M Bardini⁶, P De Lorenzo⁷, M G Valsecchi⁷, M Stanulla⁸, M Iglesias⁹, P Ballerini¹⁰, Á M Carcaboso¹¹, J Mora¹¹, F Locatelli¹², A Bertaina¹², L Padilla¹³, Juan Carlos Rodríguez-Manzaneque⁴, C Bueno^{14

15}, P Menéndez^{16

17

18}

Affiliations

¹ Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine,, University of Barcelona, Barcelona, Spain.
² Erasmus University Medical Center, Rotterdam, The Netherlands.
³ Princess Maxima Center for Paediatric Oncology, Utrecht, The Netherlands.
⁴ GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, Granada, Spain.
⁵ Oncohematología, Hospital Universitario Niño Jesús, Madrid, Spain.
⁶ Centro Ricerca Tettamanti, University of Milano-Bicocca, Ospedale San Gerardo Monza, Italy.
⁷ Interfant Trial Data Center, University of Milano-Bicocca, Monza, Italy.
⁸ Department of Pediatric Hemato-Oncology, Hannover Medical School, Hannover, Germany.
⁹ Pathology Service, Hospital del Mar, Barcelona, Spain.
¹⁰ Pediatric Hematology, A. Trousseau Hospital, Paris, France.
¹¹ Developmental Tumor Biology Laboratory, Hospital Sant Joan de Deu, Barcelona, Spain.
¹² Department of Pediatric Hematology and Oncology, Ospedale Bambino Gesù, Rome, University of Pavia, Pavia, Italy.
¹³ Biomed Division, LEITAT Technological Centre, Barcelona, Spain.
¹⁴ Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine,, University of Barcelona, Barcelona, Spain. cbueno@carrerasresearch.org.
¹⁵ Centro de Investigacion Biomedica en Red-Oncología (CIBERONC), Barcelona, Spain. cbueno@carrerasresearch.org.
¹⁶ Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine,, University of Barcelona, Barcelona, Spain. pmenendez@carrerasresearch.org.
¹⁷ Centro de Investigacion Biomedica en Red-Oncología (CIBERONC), Barcelona, Spain. pmenendez@carrerasresearch.org.
¹⁸ Instituciò Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain. pmenendez@carrerasresearch.org.

Abstract

The original version of this Article contained an error in the spelling of the author Juan Carlos Rodriguez-Manzaneque, which was incorrectly given as J Carlos Rodríguez-Manzaneque. This has now been corrected in both the PDF and HTML versions of the Article.

Publication types

Published Erratum